QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
Malaria is a disease caused by protozoan parasites of the genus Plasmodium that affects millions of people worldwide. In recent years there have been parasite resistances to several drugs, including the first-line antimalarial treatment. With the aim of proposing new drugs candidates for the treatme...
Main Authors: | Letícia Santos-Garcia, Marco Antônio de Mecenas Filho, Kamil Musilek, Kamil Kuca, Teodorico Castro Ramalho, Elaine Fontes Ferreira da Cunha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/9/2348 |
Similar Items
-
QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human <i>N</i>-Myristoyltransferase (Hs-NMT) Inhibitors
by: Magdi E. A. Zaki, et al.
Published: (2021-03-01) -
Analyzing a potential drug target N-myristoyltransferase of Plasmodium falciparum through in silico approaches
by: Amit Kumar Banerjee, et al.
Published: (2012-01-01) -
The role of N-myristoyltransferase 1 in tumour development
by: Hong Wang, et al.
Published: (2023-12-01) -
Inhibition of N‐myristoyltransferase1 affects dengue virus replication
by: San Suwanmanee, et al.
Published: (2019-09-01) -
The Potential Use of N-Myristoyltransferase as a Biomarker in the Early Diagnosis of Colon Cancer
by: Rajendra K Sharma, et al.
Published: (2011-03-01)